Bath & Body Works, Inc. $BBWI Shares Purchased by Dynamic Technology Lab Private Ltd

Key Points

• Dynamic Technology Lab Private Ltd increased its stake in Bath & Body Works by 50.5% during Q1, now owning 102,040 shares valued at approximately $3,094,000.
• Analysts have set a consensus price target of $41.62 for BBWI, with twelve rating it a "buy" and three a "hold".
• The company recently announced a quarterly dividend of $0.20 per share, reflecting an annualized yield of 2.7%.

Dynamic Technology Lab Private Ltd grew its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 50.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 102,040 shares of the company's stock after acquiring an additional 34,231 shares during the quarter. Bath & Body Works comprises about 0.4% of Dynamic Technology Lab Private Ltd's holdings, making the stock its 14th largest position. Dynamic Technology Lab Private Ltd's holdings in Bath & Body Works were worth $3,094,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently modified their holdings of the company. Wealth Enhancement Advisory Services LLC increased its stake in shares of Bath & Body Works by 38.9% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 41,711 shares of the company's stock valued at $1,265,000 after acquiring an additional 11,681 shares during the last quarter. Merit Financial Group LLC acquired a new stake in Bath & Body Works during the 1st quarter worth approximately $714,000. Nuveen Asset Management LLC increased its position in Bath & Body Works by 3.7% during the 4th quarter. Nuveen Asset Management LLC now owns 764,195 shares of the company's stock worth $29,628,000 after purchasing an additional 27,136 shares in the last quarter. Assenagon Asset Management S.A. increased its position in Bath & Body Works by 3,642.2% during the 1st quarter. Assenagon Asset Management S.A. now owns 1,651,109 shares of the company's stock worth $50,062,000 after purchasing an additional 1,606,988 shares in the last quarter. Finally, Tremblant Capital Group acquired a new stake in Bath & Body Works during the 4th quarter worth approximately $6,891,000. Institutional investors and hedge funds own 95.14% of the company's stock.

Bath & Body Works Price Performance

NYSE BBWI traded down $0.57 during trading hours on Friday, hitting $27.31. 2,416,254 shares of the company's stock traded hands, compared to its average volume of 5,296,643. Bath & Body Works, Inc. has a 52-week low of $24.94 and a 52-week high of $41.87. The company has a market capitalization of $5.63 billion, a PE ratio of 8.10, a PEG ratio of 0.96 and a beta of 1.49. The firm's 50-day moving average is $30.43 and its 200-day moving average is $30.26.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.37. The company had revenue of $1.55 billion during the quarter, compared to analysts' expectations of $1.55 billion. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. Bath & Body Works's revenue was down .8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.37 EPS. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. Equities research analysts predict that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 5th. Shareholders of record on Friday, August 22nd were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 2.9%. The ex-dividend date was Friday, August 22nd. Bath & Body Works's payout ratio is presently 23.74%.

Analyst Ratings Changes

A number of analysts recently issued reports on BBWI shares. Citigroup dropped their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a "buy" rating for the company in a research report on Tuesday, August 19th. UBS Group dropped their target price on shares of Bath & Body Works from $36.00 to $32.00 and set a "neutral" rating for the company in a research report on Friday, August 29th. JPMorgan Chase & Co. upped their price target on Bath & Body Works from $40.00 to $46.00 and gave the stock an "overweight" rating in a report on Monday, July 28th. Piper Sandler set a $39.00 price target on Bath & Body Works and gave the stock an "overweight" rating in a report on Thursday, May 15th. Finally, Wall Street Zen cut Bath & Body Works from a "buy" rating to a "hold" rating in a report on Saturday, August 9th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $39.69.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.